DOI: 10.1369/jhc.3A6245.2004
Journal of Histochemistry and Cytochemistry
Volume 52 (6): 735-748, 2004
Copyright ©The Histochemical Society, Inc.
Expression and Characterization of Murine Hevin (SC1), a Member of the SPARC Family of Matricellular Proteins
Rolf A. Brekken1,
Millicent M. Sullivan,
Gail Workman,
Amy D. Bradshaw2,
Juliet Carbon,
Anthony Siadak3,
Carrie Murri,
Paul E. Framson and
E. Helene Sage
Department of Vascular Biology, The Hope Heart Institute, Seattle, Washington
Correspondence to: E. Helene Sage, PhD, Dept. of Vascular Biology, The Hope Heart Institute, 1124 Columbia St., Seattle, WA 98104-2046. E-mail: hsage{at}hopeheart.org
Hevin, also known as SC1, MAST 9, SPARC-like 1, RAGS1 and ECM2, is a member of the SPARC-related family of matricellular proteins. Mouse hevin is 53% identical to mouse SPARC, and both proteins share a follistatin-like module and an extracellular Ca2+-binding (E-C) domain. SPARC functions as a modulator of cellmatrix interactions, a regulator of growth factor activity, a de-adhesive protein, and a cell cycle inhibitor. Although the functions of mouse hevin are unknown, its human orthologue has been shown to be de-adhesive for endothelial cells. We now report the production of recombinant mouse hevin in insect cells through the use of a baculoviral expression system and its purification by anion-exchange, size-exclusion chromatography, and isoelectric focusing. Furthermore, we have produced rat anti-hevin monoclonal antibodies (MAbs) that have been characterized by indirect and capture ELISAs, immunoblotting, immunoprecipitation, and immunohistochemistry (IHC). Recombinant hevin, present as a soluble factor or bound to tissue-culture plastic, inhibited the spreading of bovine aortic endothelial cells in vitro. IHC analysis of hevin in normal human and mouse tissues revealed a limited expression pattern in many tissues, with particularly dominant staining in dermis, ducts, vasculature, muscle, and brain. In lung and pancreatic tumor xenografts, we found distinct reactivity with MAbs that were selective for stromal cells, tumor cells, and/or endothelial cells. Although similar to SPARC in its anti-adhesive activities, hevin nevertheless exhibits a distinctive histological distribution that, in certain invasive tumors, is associated with desmoplasia.
(J Histochem Cytochem 52:735748, 2004)
Key Words: hevin/SC1 matricellular SPARC ECM monoclonal antibodies

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
W. D. Hardie, T. R. Korfhagen, M. A. Sartor, A. Prestridge, M. Medvedovic, T. D. Le Cras, M. Ikegami, S. C. Wesselkamper, C. Davidson, M. Dietsch, et al.
Genomic Profile of Matrix and Vasculature Remodeling in TGF-{alpha} Induced Pulmonary Fibrosis
Am. J. Respir. Cell Mol. Biol.,
September 1, 2007;
37(3):
309 - 321.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. M. Sullivan, T. H. Barker, S. E. Funk, A. Karchin, N. S. Seo, M. Hook, J. Sanders, B. Starcher, T. N. Wight, P. Puolakkainen, et al.
Matricellular Hevin Regulates Decorin Production and Collagen Assembly
J. Biol. Chem.,
September 15, 2006;
281(37):
27621 - 27632.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Kunz, J. Hoffend, A. Altmann, A. Dimitrakopoulou-Strauss, D. Koczan, M. Eisenhut, G. A. Bonaterra, T. J. Dengler, W. Mier, U. Haberkorn, et al.
Angiopoietin-2 Overexpression in Morris Hepatoma Results in Increased Tumor Perfusion and Induction of Critical Angiogenesis-Promoting Genes
J. Nucl. Med.,
September 1, 2006;
47(9):
1515 - 1524.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Kzhyshkowska, G. Workman, M. Cardo-Vila, W. Arap, R. Pasqualini, A. Gratchev, L. Krusell, S. Goerdt, and E. H. Sage
Novel Function of Alternatively Activated Macrophages: Stabilin-1-Mediated Clearance of SPARC
J. Immunol.,
May 15, 2006;
176(10):
5825 - 5832.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Q. Yan, N. Perdue, D. Blake, and E. H. Sage
Absence of SPARC in Murine Lens Epithelium Leads to Increased Deposition of Laminin-1 in Lens Capsule
Invest. Ophthalmol. Vis. Sci.,
December 1, 2005;
46(12):
4652 - 4660.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. H. Barker, G. Baneyx, M. Cardo-Vila, G. A. Workman, M. Weaver, P. M. Menon, S. Dedhar, S. A. Rempel, W. Arap, R. Pasqualini, et al.
SPARC Regulates Extracellular Matrix Organization through Its Modulation of Integrin-linked Kinase Activity
J. Biol. Chem.,
October 28, 2005;
280(43):
36483 - 36493.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. H. Barker, P. Framson, P. A. Puolakkainen, M. Reed, S. E. Funk, and E. H. Sage
Matricellular Homologs in the Foreign Body Response: Hevin Suppresses Inflammation, but Hevin and SPARC Together Diminish Angiogenesis
Am. J. Pathol.,
March 1, 2005;
166(3):
923 - 933.
[Abstract]
[Full Text]
[PDF]
|
 |
|
The Journal of Histochemistry & Cytochemistry
is owned, published, and licensed by
The Histochemical Society © 2004
|
|
|